Předměty
Publikace
- ANCA-asociovaná vaskulitida s protilátkami proti proteináze 3 je geneticky odlišná od vaskullitidy s protilátkami proti myeloperoxidáze. Komentář k: NEJM 367,2012,214-2232012 | 1. lékařská fakulta
- Elimination and penetration of amikacin into urine in patients with decreased glomerular filtration rate2024 | 1. lékařská fakulta, Ústřední knihovna
- CZecking heart failure in patients with advanced chronic kidney disease (Czech HF-CKD): Study protocol2024 | 1. lékařská fakulta
- Data quality and patient characteristics in European ANCA-associated vasculitis registries: data retrieval by federated querying2024 | 1. lékařská fakulta
- Nephrology Partnership for Advancing Technology in Healthcare (N-PATH) program: the teachers' perspective2024 | 1. lékařská fakulta
- Clinical features, outcomes, and response to corticosteroid treatment of acute tubulointerstitial nephritis: a single centre retrospective cohort study in Czech Republic2023 | 1. lékařská fakulta, 3. lékařská fakulta
- The management of lupus nephritis as proposed by EULAR/ERA 2019 versus KDIGO 20212023 | 1. lékařská fakulta
- Predictors of hypogammaglobulinemia in ANCA-associated vasculitis after a rituximab-based induction: a multicentre study2023 | 1. lékařská fakulta
- Risk Stratification to Predict Renal Survival in Anti-Glomerular Basement Membrane Disease2023 | 1. lékařská fakulta
- Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy2023 | 1. lékařská fakulta
Loading network view...